Author:
Honda Takeshi,Kanaoka Yuji,Furukawa Hiroshi,Tamura Taishi,Kuwada Noriaki,Yamasawa Takahiko,Watanabe Yoshiko,Yunoki Yasuhiro,Tabuchi Atsushi,Tanemoto Kazuo
Abstract
Abstract
Objectives
The aim of this study is to evaluate the possibility of the autologous platelet-rich plasma (PRP) collection from the cardiopulmonary bypass (CPB) circuit and to evaluate its effect on the aggregative function.
Methods
For seventy-two patients undergoing cardiac surgery with CPB, an autologous PRP was prepared using the Haemonetics Component Collection System® by drawing blood from the CPB circuit immediately after CPB was established. The blood samples were taken at three points for examination, A: beginning of surgery, B: immediately after heparin reversal with protamine following discontinuation of CPB, C: after the collected autologous PRP was returned to the patient. Platelet count and platelet aggregation ability were analyzed.
Results
The mean platelet count in autologous PRP was 5.5 (range: 3–14) units. Platelet count decreased by 115.0 (±27.3) × 1000/μl from A to B and increased by 27.3 ± 17.2 (× 1000/μl) from B to C.
When platelet aggregation was measured by Adenosine Diphosphate (ADP) 3.0 μM, it decreased by 42.6% ± 12.1% from A to B and increased by 8.7% ± 7.4% from B to C.
Conclusions
Autologous PRP can be safely collected by drawing blood from the CPB circuit, platelet count and aggregation ability significantly decreased after CPB including autologous PRP collection. Some improvement was detected in the number of the platelets count and platelet aggregation ability by administrating an autologous PRP even if autologous PRP is collected from CPB circuit.
Trial registration
UMI-CTR, UMIN000023776. Registered 1 October 2016.
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,General Medicine,Surgery,Pulmonary and Respiratory Medicine
Reference12 articles.
1. Stover EP, Siegel LC, Hood PA, O’Riordan GE. Platelet-rich plasmapheresis with therapeutic platelet yield reduces allogenic red cell and platelet transfusions in high risk cardiac surgery. Anesthesiology. 1996;85:A68.
2. Kleinman S, Chan P, Robillard P. Risks associated with transfusion of cellular blood components in Canada. Transfus Med Rev. 2003;17:120–62.
3. Zhou SF, Estrera AL, Loubser P, Ignacio C, Panthayi S, Miller III, et al. Autologous platelet-rich plasma reduces transfusions during ascending aortic arch repair: a prospective, randomized, controlled trial. Ann Thorac Surg. 2015;99:1282–90.
4. Takiuchi H, Tanemoto K. Impact of systemic heparinization on platelet function in autologous platelet-rich plasma. Kawasaki Med J. 2015;41:143–51.
5. Verrier ED, Boyle EM Jr. Endothelial cell injury in cardiovascular surgery. Ann Thorac Surg. 1996;62:915–22.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献